Wang Ching-Yu, Brown Joshua
Center for Drug Evaluation & Safety, Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Visc Med. 2020 Aug;36(4):304-310. doi: 10.1159/000502894. Epub 2019 Sep 24.
The appropriateness of using readmission rate after pancreatic surgery among pancreatic cancer patients as a quality metric to evaluate hospital performance has been widely discussed in the literature.
The present study reported readmission rate using Nationwide Readmissions Database (NRD), examined the reasons and risk factors for readmissions, and evaluated the appropriateness of using it as a quality metric.
We analyzed 3,619 patient discharge records in 2014. The outcome of interest was all-cause 30-day readmission. Reasons for readmission were grouped into clinical associated categories. Hierarchical regression model was used for examining the relationship between risk factors and readmission.
The 30-day readmission rate was 20.95%. The most common reason for readmission was surgery-related complication. In descriptive analyses, age, certain comorbidities, number of chronic conditions, mortality risk, severity of illness, living at large metropolitan area, resident of the state where patients received initial care, postoperative complication, length of stay, discharge location, and receiving care at the hospitals in large metropolitan area were predictive of readmission. In multivariable analysis, age, depression, peripheral vascular disorder, mortality risk, and discharge location were independently associated with readmission. The intraclass correlation coefficient was 0.41 for hierarchical regression model.
Readmission after pancreatic surgery remains an important issue. Our study found the majority of variation in readmissions is accounted for by patient factors whereas there was little between hospital variation. This finding does not support the use of readmission rate after pancreatic surgery as a quality metric.
胰腺癌患者胰腺手术后再入院率作为评估医院绩效的质量指标是否合适,在文献中已得到广泛讨论。
本研究报告了使用全国再入院数据库(NRD)得出的再入院率,分析了再入院的原因和风险因素,并评估了将其用作质量指标的合理性。
我们分析了2014年3619例患者的出院记录。感兴趣的结果是全因30天再入院情况。再入院原因分为临床相关类别。采用分层回归模型来研究风险因素与再入院之间的关系。
30天再入院率为20.95%。最常见的再入院原因是手术相关并发症。在描述性分析中,年龄、某些合并症、慢性病数量、死亡风险、疾病严重程度、居住在大城市地区、在接受初始治疗的州居住、术后并发症、住院时间、出院地点以及在大城市地区医院接受治疗等因素可预测再入院情况。在多变量分析中,年龄、抑郁症、外周血管疾病、死亡风险和出院地点与再入院独立相关。分层回归模型的组内相关系数为0.41。
胰腺手术后再入院仍然是一个重要问题。我们的研究发现,再入院情况的大部分差异是由患者因素造成的,而医院之间的差异很小。这一发现不支持将胰腺手术后的再入院率用作质量指标。